View Older Stories View More Recent Stories

May 8, 2026 02:57AM TD Cowen Upgrades PTC Therapeutics (PTCT) to Buy
May 7, 2026 04:14PM PTC Therapeutics (PTCT) Tops Q1 EPS by 43c, provides guidance
Apr 28, 2026 04:05PM PTC Therapeutics reports positive results for Huntington's drug votoplam
Apr 9, 2026 04:30PM Raymond James Starts PTC Therapeutics (PTCT) at Outperform
Mar 27, 2026 04:16PM Jefferies Downgrades PTC Therapeutics (PTCT) to Hold
Feb 23, 2026 06:42AM PTC Therapeutics (PTCT) PT Raised to $92 at Morgan Stanley
Feb 20, 2026 10:00AM Cantor Fitzgerald Reiterates Overweight Rating on PTC Therapeutics (PTCT)
Feb 19, 2026 04:03PM PTC Therapeutics (PTCT) Misses Q4 EPS by $1.41, Offers Guidance
Feb 12, 2026 05:00PM PTC Therapeutics withdraws Translarna drug application after FDA feedback
Feb 5, 2026 06:45AM PTC Therapeutics (PTCT) PT Lowered to $200 at Rosenblatt
Jan 28, 2026 06:20AM Barclays Starts PTC Therapeutics (PTCT) at Overweight, 'We think PKU could be >$2B at peak'
Jan 12, 2026 08:31AM PTC Therapeutics reports Q4 Sephience revenue of $92.5 million
Dec 22, 2025 07:01AM PTC Therapeutics receives approval for PKU drug Sephience in Japan
Dec 3, 2025 04:36AM PTC Therapeutics (PTCT) PT Raised to $55 at Goldman Sachs
Dec 1, 2025 05:09AM RBC Capital Downgrades PTC Therapeutics (PTCT) to Sector Perform
Nov 24, 2025 05:18PM Sandisk (SNDK) to join S&P 500
Nov 24, 2025 05:17PM Sandisk to Join S&P 500; Upwork, First Interstate BancSystem, PTC Therapeutics to Join S&P SmallCap 600
Nov 19, 2025 07:25AM PTC Therapeutics (PTCT) 'Remains a Top Pick' - Cantor Fitzgerald
Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers
Nov 5, 2025 05:35AM PTC Therapeutics (PTCT) PT Raised to $78 at Morgan Stanley
Nov 5, 2025 04:45AM PTC Therapeutics (PTCT) PT Raised to $50 at Goldman Sachs
Nov 4, 2025 04:14PM PTC Therapeutics (PTCT) Tops Q3 EPS by $1.32
Nov 3, 2025 10:00AM Truist: 'QURE Update Minimal Read-Through To PTCT & WVE, In Our View'
Oct 20, 2025 05:12AM PTC Therapeutics (PTCT) PT Raised to $87 at BofA Securities
Sep 8, 2025 09:44AM BofA Securities on Top Pick PTC Therapeutics (PTCT): 'We also see opportunity for upside within the pipeline'
Aug 19, 2025 12:11PM Goldman Sachs Reiterates Sell Rating on PTC Therapeutics (PTCT)
Aug 19, 2025 11:49AM Leerink Partners Reiterates Market Perform Rating on PTC Therapeutics (PTCT)
Aug 19, 2025 11:27AM PTC Therapeutics (PTCT) PT Lowered to $63 at Jefferies
Aug 19, 2025 11:01AM Truist Securities Reiterates Buy Rating on PTC Therapeutics (PTCT)
Aug 19, 2025 10:50AM PTC Therapeutics (PTCT) PT Lowered to $76 at BofA Securities
Aug 19, 2025 08:01AM FDA rejects PTC Therapeutics' vatiquinone for Friedreich's ataxia
Aug 19, 2025 07:55AM PTC Therapeutics (PTCT) Halted, News Pending
Aug 8, 2025 08:51AM PTC Therapeutics (PTCT) PT Raised to $63 at RBC Capital
Aug 8, 2025 08:17AM PTC Therapeutics (PTCT) PT Raised to $56 at TD Cowen
Aug 7, 2025 04:09PM PTC Therapeutics (PTCT) Tops Q2 EPS by 23c, provides guidance
Aug 7, 2025 09:05AM PTC Therapeutics (PTCT) PT Raised to $68 at JPMorgan, 'We believe the Sephience franchise will secure the next chapter of growth'
Jul 29, 2025 10:08AM PTC Therapeutics (PTCT) PT Raised to $80 at UBS
Jul 29, 2025 08:54AM PTC Therapeutics (PTCT) PT Raised to $86 at Truist Securities
Jul 29, 2025 08:30AM PTC Therapeutics (PTCT) PT Raised to $120 at Cantor Fitzgerald
Jul 28, 2025 04:34PM PTC Therapeutics (PTCT) to Resume Trading at 4:50 p.m.
Jul 28, 2025 04:19PM PTC Therapeutics receives FDA approval for PKU treatment drug
Jul 28, 2025 03:32PM PTC Therapeutics (PTCT) Halted, News Pending
Jul 25, 2025 08:35AM Citi Opens Upside 30d Catalyst Watch on PTC Therapeutics (PTCT)
Jul 14, 2025 09:56AM UBS Reiterates Buy Rating on PTC Therapeutics (PTCT)
Jun 17, 2025 06:04AM Truist Securities Starts PTC Therapeutics (PTCT) at Buy
Jun 4, 2025 05:10AM PTC Therapeutics (PTCT) PT Raised to $60 at RBC Capital
Jun 2, 2025 10:33AM Citi Reiterates Neutral Rating on PTC Therapeutics (PTCT)
Jun 2, 2025 10:23AM RBC Capital Reiterates Outperform Rating on PTC Therapeutics (PTCT)
May 8, 2025 04:49PM BofA Securities Upgrades PTC Therapeutics (PTCT) to Buy
May 7, 2025 06:00AM William Blair Reiterates Outperform Rating on PTC Therapeutics (PTCT)
View More Recent Stories View Older Stories